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Case presentation
A boy with systemic juvenile arthritis (sJIA) for 7 years,
treated with prednisone 1 mg/kg/day, NSAIDS, Meth-
otrexate and TNF-α antagonism, presented at age 15 with
severe incapacitating back pain.
Clinically, a cachectic and stunted boy, weight and height
SD scores were -5,05 and -3,65 respectively. He had fever,
anaemia, splenomegaly and polyartrhitis. There was com-
plete immobility and severe pain of his lumbar spine. X-
rays revealed compression fractures of all lumbar verte-
brae. Bone mass densitometry confirmed severe oste-
oporosis (Z-score -4.5 SD). ESR: 33, Hb: 7.4 g/dl, CRP 112
mg/dl.
IL-1 receptor antagonism resulted in a rapid major
improvement. Within a few weeks, there was no fever, no
arthritis, no splenomegaly, with normal CRP, ESR and
Haemoglobin.
Body composition changed dramatically; weight increas-
ing by 10 kg (SDS -2,9) and body fat fraction (DEXA)
from 17% to 35%, despite weaning steroids from 1 to 0,3
mg/kg/day. Bone Z-score improved to -3,3 SD.
Discussion
The present case illustrates the striking effectiveness of Il-
1 receptor antagonism in a patient with severe refractory
sJIA, and steroid dependency (with devastating side
effects, esp on bone mineralization). IL1-ra has been asso-
ciated with obesity in adults [1,2]. IL1 receptor antago-
nism was associated with an important change of body
composition in this patient. It remains to be clarified how
the interplay between inflammation, Il-1 blockade and
corticosteroid therapy impacts on body composition and
fat metabolism.
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